(RTTNews) - Dr. Reddy's Laboratories Ltd. (DRREDDY, RDY), on Wednesday, announced the launch of over-the-counter or OTC Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren Arthritis ...
Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously ...
Dr. Reddy’s is offering over-the-counter diclofenac sodium topical gel 1%, the store brand version of GSK Consumer Healthcare's Voltaren Arthritis Pain. “The launch of Dr. Reddy’s diclofenac sodium ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand ...
WARREN, N.J., Feb. 17, 2020 /PRNewswire/ -- GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback